Hence the observed lack of significant elevation in serum IL-4 levels across all the treatment groups was attributed to the study being centred around a primary infection as opposed to a secondary infection (or re-infection) where this cytokine (IL-4) reportedly partakes in the immune response(s). This evidence concerns the gene IL4 and infection.